Meatable

Meatable developed a patented method to grow real muscle and fat cells from pluripotent stem cells at speed and with 100% efficiency, aiming to produce animal-free pork products. [1]

Where it wins

• First company in the European Union to receive regulatory approval from the EFSA for a public tasting of cultured meat (sausage). [2]
• Only method to grow real muscle and fat cells from pluripotent stem cells at speed and with 100% efficiency. [1]
• Strategic partnerships with industry leaders like DSM to make cultured meat affordable and accessible on a large scale. [2]
• Acquired Uncommon Bio’s cultivated meat platform, including key technology, IP assets, and high-performing cell lines. [1]

Credibility: EU-Startups, Vegconomist, Food Processing

• Developed a patented method to grow real muscle and fat cells from pluripotent stem cells. [1]
• Focused on producing animal-free pork products. [2]
• Collaborated with industry leaders like DSM to scale production and affordability. [2]
• Acquired Uncommon Bio’s platform to enhance technology and cell lines. [1]
• Sought to establish a high-volume production facility in Singapore with TruMeat. [1]

Credibility: EU-Startups, Vegconomist, Food Processing

• Believer Meats: Another cultivated meat company that recently shut down. [4]
• Mosa Meat: European rival that secured €15 million funding. [1]
• Traditional meat industry: Competing for market share with animal-free alternatives. [3]
• Other alternative protein companies: Facing similar financial and regulatory challenges. [4]

Differentiators: Meatable’s patented technology and first EU regulatory approval for public tasting. [2]

Credibility: EU-Startups, Vegconomist, Food Processing

• Demand for sustainable, animal-free meat products. [2]
• Need for affordable and accessible cultured meat. [2]
• Regulatory hurdles for bringing cultured meat to market. [2]
• Financial challenges in scaling cellular agriculture companies. [1]
• Competition from traditional meat and other alternative protein sources. [3]

Credibility: EU-Startups, Vegconomist, Food Processing

Meatable's dissolution highlights the significant financial and regulatory challenges in the cultivated meat sector. The company's patented technology and strategic partnerships were key strengths, but insufficient funding ultimately led to its closure. The industry faces a critical need for scalable production and cost reduction to compete with traditional meat. Future success will depend on securing sustained investment and navigating regulatory landscapes effectively.

Meatable should have diversified its revenue streams beyond product sales to include technology licensing and consulting. The company could have focused on niche markets with higher willingness to pay for cultured meat. Strengthening partnerships with traditional meat companies could have provided a more stable supply chain and market access. Meatable should have prioritized regulatory approvals in multiple regions to mitigate regional risks.